Benzinga's Top Upgrades

Analysts at KeyBanc upgraded Transdigm Group (NYSE: TDG ) from “hold” to “buy.” The target price for Transdigm Group is set to $170. Transdigm Group's shares closed at $145.85 yesterday. Analysts at Liberum upgraded Astrazeneca PLC (NYSE: AZN ) from “undefined to “buy.” Astrazeneca's shares closed at $52.99 yesterday. Raymond